Please login to the form below

Not currently logged in
Email:
Password:

GVK Biosciences

This page shows the latest GVK Biosciences news and features for those working in and with pharma, biotech and healthcare.

EMA suspends generic drugs on data integrity concerns

EMA suspends generic drugs on data integrity concerns

Last year, the EMA also suspended marketing authorisations for scores of products relying on bioequivalence data provided by GVK Biosciences after uncovering similar issues.

Latest news

  • Does 'trust leadership' feature in your strategy? Does 'trust leadership' feature in your strategy?

    The EMA was announcing the suspension of dozens of product licences, including ones from Sanofi, Sandoz and others, because of flawed trials by Indian contractor GVK Biosciences.

  • Indian generics firm GVK set to be hit with European sales ban Indian generics firm GVK set to be hit with European sales ban

    The European Medicines Agency (EMA) has recommended suspending sales of hundreds of generic medicines produced by India-based GVK Biosciences over concerns about the conduct of clinical trials carried out by ... However, despite its concerns the EMA added

  • Endo to collaborate with India-based CRO GVK Biosciences Endo to collaborate with India-based CRO GVK Biosciences

    Manni Kantipudi, CEO of GVK Biosciences, said: “We are delighted to partner with Endo as it continues to build its discovery pipeline through external collaborations. ... The collaboration with Endo comes in the same month that GVK Biosciences entered

  • News in Brief, May 30, 2007

    Wyeth and GVK project to commence June. The joint drug-discovery project of US pharmaceutical company, Wyeth, and Indian biopharmaceutical firm, GVK Biosciences will begin in June 2007, following the establishment ... About 50 scientists are working for

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics